Ji X, Liu Y, Wang Y, Zhao H
Department of Pathology, Chinese PLA General Hospital, Beijing, PR China.
J Environ Pathol Toxicol Oncol. 1999;18(1):65-71.
Hepatic arterial embolization (HAE) is used to treat hepatocellular carcinoma (HCC), but little is known about the histopathological changes occurring after HAE. Thirty-nine cases of liver neoplasms treated with HAE and 11 cases of liver neoplasms after digital selective angiography (DSA) were analyzed histopathologically. The pathological type, histological grade, degree of necrosis, capsular changes, number of HAE, vessel injury, and lymphocytic infiltration were recorded. Six cases showed 100% necrosis, 14 cases had 30 to 95% necrosis, and 19 cases 0 to 5% necrosis after HAE. Eleven cases of DSA did not reveal histological features of necrosis. The necrosis was related to the pathological type of tumor, encapsulation, and degree of vascular injury and was independent of histological grade, number of HAE, or lymphocytic infiltration of the neoplasm. HAE is an effective therapy for advanced stage of HCC. The encapsulated HCC is a preferred indicator for HAE.
肝动脉栓塞术(HAE)用于治疗肝细胞癌(HCC),但关于HAE术后发生的组织病理学变化知之甚少。对39例接受HAE治疗的肝脏肿瘤病例和11例数字选择性血管造影(DSA)术后的肝脏肿瘤病例进行了组织病理学分析。记录病理类型、组织学分级、坏死程度、包膜变化、HAE次数、血管损伤及淋巴细胞浸润情况。HAE术后6例显示100%坏死,14例坏死率为30%至95%,19例坏死率为0%至5%。11例DSA检查未显示坏死的组织学特征。坏死与肿瘤的病理类型、包膜、血管损伤程度有关,与组织学分级、HAE次数或肿瘤的淋巴细胞浸润无关。HAE是治疗晚期HCC的有效方法。有包膜的HCC是HAE的首选指标。